• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

12.91 -0.42 (-3.15%)
Streaming Delayed Price Updated: 3:11 PM EDT, Jun 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
News headline image
Compass Pathways Elects Kathleen Tregoning to Board of Directors
May 28, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026
May 26, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins ↗
May 21, 2026
Compass Pathways (NASDAQ:CMPS) executives said the company remains on track to target a fourth-quarter New Drug Application filing for COMP360, its synthetic psilocybin treatment candidate for... 
Via MarketBeat
Topics Cannabis Government
News headline image
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
May 14, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass (CMPS) Q1 2026 Earnings Transcript ↗
May 13, 2026
Compass (CMPS) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Compass Pathways Q1 Earnings Call Highlights ↗
May 13, 2026
Compass Pathways (NASDAQ:CMPS) said it has begun a rolling New Drug Application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, and is preparing for... 
Via MarketBeat
Topics Cannabis Earnings Government
News headline image
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights
May 13, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026
May 06, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
These 3 Psychedelic Stocks Activated After Trump's Executive Order ↗
April 27, 2026
Via MarketBeat
Topics Government
News headline image
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher
April 24, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Trump Backs Psychedelics. Here's 1 Company Investors Need to Know About ↗
April 23, 2026
Compass Pathways is already in the final stage of development on a psychedelic medicine to treat depression. 
Via The Motley Fool
Topics Government
News headline image
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments
April 21, 2026
From Compass Pathfinder Limited
Via Business Wire
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up ↗
April 21, 2026
Via Chartmill
News headline image
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
April 20, 2026
Via AB Newswire
News headline image
This 4/20, Wall Street Is Betting on More Than Marijuana ↗
April 20, 2026
Via MarketBeat
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
April 20, 2026
Via Chartmill
News headline image
This Psychedelic Biotech Stock Is Soaring After Trump Executive Order ↗
April 20, 2026
COMPASS Pathways PLC (NASDAQ:CMPS) shares are soaring on Monday after President Donald Trump issued an executive order directing federal health agencies to speed up the review process for... 
Via Benzinga
Topics Government
What's going on in today's session ↗
April 20, 2026
Via Chartmill
News headline image
Why Compass Pathways Stock Rocketed 40% Today ↗
April 20, 2026
Compass Pathways may be the first to benefit from an accelerated approval process. 
Via The Motley Fool
Topics Government
News headline image
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar ↗
April 20, 2026
Trump is easing approval for psychedelic treatments for mental disorders. 
Via The Motley Fool
Topics Government
These stocks are gapping in today's session ↗
April 20, 2026
Via Chartmill
Top movers in Monday's pre-market session ↗
April 20, 2026
Via Chartmill
News headline image
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
April 20, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
April 18, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
The Psychedelic Revolution in Mental Healthcare ↗
April 17, 2026
Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, discuss their new book, Psychedelic Therapy: A Revolutionary Approach to Restoring Mental Health and... 
Via The Motley Fool
News headline image
Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training
April 14, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026
April 08, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 07, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
March 26, 2026
Today’s Date: March 26, 2026 Introduction As the global mental health crisis reaches unprecedented levels, the pharmaceutical industry has been forced to look beyond traditional SSRIs toward more... 
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap